Advertisement
Advertisement
U.S. markets close in 4 hours 4 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Aeglea BioTherapeutics, Inc. (AGLE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
0.4349+0.0224 (+5.43%)
As of 11:56AM EDT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/8/2022
Current
6/30/20223/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
25.71M30.90M113.53M234.27M390.06M341.21M
Enterprise Value
-36.09M-30.90M25.46M127.00M266.78M219.87M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
1.381.658.0720.6237.54N/A
Price/Book (mrq)
0.420.501.352.303.292.76
Enterprise Value/Revenue
-5.13-49.4418.7034.85190.6916.05
Enterprise Value/EBITDA
0.421.40-1.06-6.34-13.42-34.86

Trading Information

Stock Price History

Beta (5Y Monthly) 1.77
52-Week Change 3-93.64%
S&P500 52-Week Change 3-7.20%
52 Week High 38.5000
52 Week Low 30.3720
50-Day Moving Average 30.5948
200-Day Moving Average 32.9633

Share Statistics

Avg Vol (3 month) 3668.55k
Avg Vol (10 day) 3250.48k
Shares Outstanding 561.17M
Implied Shares Outstanding 6N/A
Float 849.24M
% Held by Insiders 12.00%
% Held by Institutions 174.25%
Shares Short (Jul 14, 2022) 41.02M
Short Ratio (Jul 14, 2022) 41.82
Short % of Float (Jul 14, 2022) 41.79%
Short % of Shares Outstanding (Jul 14, 2022) 41.66%
Shares Short (prior month Jun 14, 2022) 42.61M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,246.07%

Management Effectiveness

Return on Assets (ttm)-43.16%
Return on Equity (ttm)-86.14%

Income Statement

Revenue (ttm)7.03M
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)-95.40%
Gross Profit (ttm)-38.33M
EBITDA -86M
Net Income Avi to Common (ttm)-87.51M
Diluted EPS (ttm)-1.0940
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)88.55M
Total Cash Per Share (mrq)1.45
Total Debt (mrq)4.79M
Total Debt/Equity (mrq)5.70
Current Ratio (mrq)6.09
Book Value Per Share (mrq)1.38

Cash Flow Statement

Operating Cash Flow (ttm)-83.2M
Levered Free Cash Flow (ttm)-52.07M
Advertisement
Advertisement